Patents

The table provides an overview of all disclosed patent applications filed by FVB for FMP technologies:

Title Publication number Applicant* Status
Inhibitors of NO production WO2022043465 MDC, FVB, Charité Published
Polyproline mimetics of proline-derived module-15 WO2019162524 FVB, Univ zu Köln Licensed
1,2,4-triazole derivatives as tankyrase inhibitors WO2019243822 Oslo Univ Hospital, FVB, Univ Oulo Published
Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors WO2019234237 FVB Published
Polyproline mimetics of proline-derived module-15 WO2019162524 FVB, Univ zu Köln Licensed
Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates WO2019170710 FVB, LMU Licensed
Selective inhibitors of genotoxic stress-induced IKK/NF-kB pathways WO2018087389 MDC, FVB Published
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates WO2018041985 FVB, LMU Licensed
Unusual substrates of tubulin tyrosine ligase WO2017186855 FVB, LMU Licensed
Antagonists of the thyroid-stimulating hormone receptor (TSHR) WO2017186793 FVB Published
Means and methods for site-specific functionalization of polypeptides WO2016066749 LMU, FVB Licensed
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same WO2016135199, WO2018019917 FVB, MDC Licensed
Inhibitors for inhibiting tumor metastasis WO2016092069 FVB, Univ zu Köln Licensed
Structural mimetics of proline-rich peptides and use thereof WO2013030111 FVB, Univ zu Köln Licensed
Induction of alpha helix conformations in proteins and peptides WO2011003626 Univ zu Köln, FVB Licensed
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists WO2010047674 US Health, FVB Licensed
Structural mimetics of proline-rich peptides and the pharmaceutical use thereof WO2008040332 FVB Licensed
*FVB - Forschungsverbund Berlin e.V. (for its Leibniz-Forschungsinstitut für Molekulare Pharmakologie); LMU - Ludwig-Maximilians-Universität München; MDC - Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft; Oslo Univ Hospital - Oslo University Hospital HF; TUM - Technische Universität München; Univ Oulo - University of Oulo; Univ zu Köln - Universität zu Köln; US Health - The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services; Charité - Charité Universitätsmedizin Berlin